The aim of this study was to compare the epigenetic profile (defined here as the pattern of DNA methylation on TCF7L2 promoter in DNA from peripheral blood) between type 2 diabetic patients and age- and BMI-matched controls. Here, TCF7L2 is linked to type 2 diabetes mellitus.